AzTrials
AzTrials

PainEarly Phase 1NCT00924963

J-Tip® Jet Injection of 1% Buffered Lidocaine or Saline Versus 4% Lidocaine Cream Before Venipuncture or IV Insertion

A Early Phase 1 study testing J-Tip jet injector, Jet injection saline and lidocaine cream in people with Pain, run by Children's Hospital Medical Center, Cincinnati at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

To measure and compare pain associated with venipuncture and peripheral intravenous catheter insertion among pediatric emergency department patients randomized to treatment with one of three different pain-reduction strategies: J-Tip® jet injection of 1% buffered lidocaine, J-Tip® jet injection of sterile saline, or… Read more about this study

Who is it for?
Ages 7 to 21 yearsHealthy volunteers can take part
Conditions the study is for
Pain
What is being tested?
J-Tip jet injector, Jet injection saline and lidocaine cream
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
0 participants
Where
1 siteUnited States
Study dates
Jun 2009to Jun 2010
Phase
Early Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 21 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Children aged seven to twenty-one years old requiring venipuncture or PIVC insertion as part of their emergency department care are eligible for the study.

Who cannot join

  • Lidocaine allergy,
  • TegadermTM allergy,
  • Glasgow Coma Score (GCS) less than 15,
  • Pain at the proposed site for the procedure,
  • Requirement of a PIVC or venipuncture immediately due to illness acuity,
  • Inability to complete a self-reported pain scale (VAS, visual analogue scale),
  • Patients who do not speak and understand English, OR
  • Previous enrollment in the study.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Cincinnati Children's Hospital Liberty Township Emergency Department

    Liberty Township, Ohio, 45044

Other trials in United States

About this study

Official title: Comparison of J-Tip® Jet Injection of 1% Buffered Lidocaine, 4% Lidocaine Topical Cream, and J-Tip® Jet Injection of Placebo Prior to Venipuncture and Peripheral Intravenous Catheter Insertion in a Pediatric Emergency Department

To measure and compare pain associated with venipuncture and peripheral intravenous catheter insertion among pediatric emergency department patients randomized to treatment with one of three different pain-reduction strategies: J-Tip® jet injection of 1% buffered lidocaine, J-Tip® jet injection of sterile saline, or application of 4% lidocaine topical cream. The investigators hypothesize that J-Tip® jet injection of 1% buffered lidocaine will provide superior local anesthesia compared to saline or lidocaine cream.

Read the detailed description

Background: Venipuncture and PIVC insertion are the most common procedures performed in the pediatric emergency department. They are painful procedures, and frequently no local anesthesia is provided. The American Academy of Pediatrics Committee on Pediatric Emergency Medicine and Section on Anesthesiology and Pain Medicine has recommended that local anesthesia be provided, but a variety of barriers exist which have prevented implementation of this recommendation.

Specific Aims: To measure and compare pain associated with venipuncture and peripheral intravenous catheter insertion among pediatric emergency department patients randomized to treatment with one of three different pain-reduction strategies: J-Tip® jet injection of 1% buffered lidocaine, J-Tip® jet injection of sterile saline, or application of 4% lidocaine topical cream.

Methods: This study is a partially blinded, placebo controlled, randomized controlled clinical trial in the pediatric emergency department. The comparison of J-Tip® jet injection of 1% buffered lidocaine to J-Tip® jet injection of sterile saline is double blinded, while the comparison of jet injection to 4% lidocaine topical cream is not blinded. Forty-four patients per group will be enrolled, and a VAS self-reported measurement will be recorded for the pain of venipuncture or PIVC insertion following the appropriate treatment. As well, success of the procedure and complications of treatment will be recorded.

Results: Pain scores will be analyzed by pairwise comparisons using a t-test and pooled comparisons using ANOVA. Demographics will be assessed to determine baseline differences among the three groups. Chi square and regression analysis will be performed on demographic differences to determine significance if necessary. Final pain results will be reported as mean, standard deviation, and p-value. Demographics will be reported as number, percent of patients, and p-value (if a difference exists).

Conditions
Pain
Being tested
J-Tip jet injector, Jet injection saline, lidocaine cream
Keywords
Pain of venipuncture or IV insertion
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • J-Tip jet injectorDevice

    Also called J-Tip jet injector with 1% buffered lidocaine

    0.2ml 1%buffered lidocaine delivered by jet injector

  • Jet injection salineDevice

    Also called J-Tip Jet injection with saline

    0.2ml saline delivered via J-Tip jet injection

  • lidocaine creamDrug

    Also called 4% lidocaine cream

    4% lidocaine cream applied for 30 minutes to the skin

Study groups in NCT00924963
Study groupRoleWhat they receive
Jet injection lidocaineExperimentalJ-Tip jet injection of 1% buffered lidocaine
Receives: Device: J-Tip jet injector
Jet injection salinePlacebo comparatorJ-Tip jet injection of sterile saline
Receives: Device: Jet injection saline
Lidocaine creamActive comparatorLidocaine 4%cream applied for 30 minutes prior to IV insertion or venipuncture
Receives: Drug: lidocaine cream

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Jet injection of 1% buffered lidocaine to 4% lidocaine topical cream to measure the effectiveness of jet injection of lidocaine as a local anesthetic prior to venipuncture and PIVC insertion

    1. Pain associated with venipuncture or PIVC insertion after pre-treatment with jet injection of 1% buffered lidocaine versus 4% lidocaine topical cream

    Measured: 30 minutes

Secondary outcomes (5)
  1. Jet injection of 1% buffered lidocaine to jet injection of saline to assess and measure a potential placebo effect not measured in prior studies

    Pain associated with venipuncture or PIVC insertion after pre-treatment with jet injection of 1% buffered lidocaine versus jet injection of sterile saline

    Measured: 30 minutes

  2. Second attempt pain scores (if occurred) among the three groups and between their first and second VAS scores

    compare pain scores across groups if a second attempt was made using VAS scores

    Measured: 30 minutes

  3. The success of venipuncture or PIVC insertion with all anesthetic techniques

    Compare all types of anesthetics during venipuncture or PIVC

    Measured: 30 minutes

  4. Variety of locations of successful venipuncture or PIVC insertion after jet injection use

    compare successful venipunctures across locations

    Measured: 30 minutes

  5. Measurement of complication rate after jet injection use

    Compare variability of complications that arise post injection across groups

    Measured: 1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jun 2009 (estimated)
  2. Study startJun 2009
  3. Primary completionJun 2010
  4. Study completionJun 2010

Why it stopped: Study ended due to lack of funding.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00924963
Sponsor's protocol ID
2008-0922
Status last verified
Sep 2020
First submitted
18 Jun 2009
Last updated
21 Sep 2020
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing J-Tip jet injector, Jet injection saline and lidocaine cream in people with Pain, run by Children's Hospital Medical Center, Cincinnati at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 21 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Jet injection of 1% buffered lidocaine to 4% lidocaine topical cream to measure the effectiveness of jet injection of lidocaine as a local anesthetic prior to venipuncture and PIVC insertion (time frame: 30 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in